0001645113-22-000037.txt : 20220413 0001645113-22-000037.hdr.sgml : 20220413 20220413160628 ACCESSION NUMBER: 0001645113-22-000037 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220411 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20220413 DATE AS OF CHANGE: 20220413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 22824778 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 8-K 1 nvcr-20220411.htm 8-K nvcr-20220411
0001645113false00016451132022-04-012022-04-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

April 11, 2022
Date of Report (date of earliest event reported)

NovoCure Limited
(Exact name of registrant as specified in its charter)
Jersey
001-37565
98-1057807
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
No. 4 The Forum, Grenville Street
St. Helier
Jersey
JE2 4UF
(Address of Principal Executive Offices)
(Zip Code)
+44 (0) 15 3475 6700
Registrant's telephone number, including area code

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Ordinary Shares, no par valueNVCRThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o



Item 5.02     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)

On April 11, 2022, Sherilyn McCoy, a Director of NovoCure Limited (the "Company") since 2018, notified the Company of her intention not to stand for reelection to the Board of Directors of the Company (the "Board") at the Company's 2022 annual general meeting of shareholders (the "Annual Meeting"), which is currently scheduled for June 8, 2022.

Ms. McCoy's decision not to stand for reelection was not due to any disagreement with the Company, but rather relates to her desire to focus on other professional commitments, and she will continue to serve on the Board until the expiration of her term at the Annual Meeting.

The Company thanks Ms. McCoy for her service and significant contributions to the Company and wishes her the best of luck in her future endeavors.

Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NovoCure Limited
(Registrant)

Date: April 13, 2022


By: /s/ Ashley Cordova
Name: Ashley Cordova
Title: Chief Financial Officer

 EX-101.SCH 2 nvcr-20220411.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 nvcr-20220411_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, Address Line One Entity Address, Address Line One Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Written Communications Written Communications Local Phone Number Local Phone Number Soliciting Material Soliciting Material City Area Code City Area Code Document Type Document Type Entity Address, Country Entity Address, Country Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Address, City or Town Entity Address, City or Town Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Trading Symbol Trading Symbol Entity Tax Identification Number Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code EX-101.PRE 4 nvcr-20220411_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information Document
 1 Months Ended
Apr. 30, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 11, 2022
Entity Registrant Name NovoCure Limited
Entity Central Index Key 0001645113
Amendment Flag false
Entity Incorporation, State or Country Code Y9
Entity File Number 001-37565
Entity Tax Identification Number 98-1057807
Entity Address, Address Line One No. 4 The Forum, Grenville Street
Entity Address, City or Town St. Helier
Entity Address, Country JE
Entity Address, Postal Zip Code JE2 4UF
City Area Code 44 (0) 15
Local Phone Number 3475 6700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Ordinary Shares, no par value
Trading Symbol NVCR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 nvcr-20220411_htm.xml IDEA: XBRL DOCUMENT 0001645113 2022-04-01 2022-04-30 0001645113 false 8-K 2022-04-11 NovoCure Limited Y9 001-37565 98-1057807 No. 4 The Forum, Grenville Street St. Helier JE JE2 4UF 44 (0) 15 3475 6700 false false false false Ordinary Shares, no par value NVCR NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Document Sheet http://www.novocure.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports nvcr-20220411.htm nvcr-20220411.xsd nvcr-20220411_lab.xml nvcr-20220411_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nvcr-20220411.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "nvcr-20220411.htm" ] }, "labelLink": { "local": [ "nvcr-20220411_lab.xml" ] }, "presentationLink": { "local": [ "nvcr-20220411_pre.xml" ] }, "schema": { "local": [ "nvcr-20220411.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nvcr", "nsuri": "http://www.novocure.com/20220411", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvcr-20220411.htm", "contextRef": "i1c8a2fb4d43f44019fc2de9c11a833ef_D20220401-20220430", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information Document", "role": "http://www.novocure.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvcr-20220411.htm", "contextRef": "i1c8a2fb4d43f44019fc2de9c11a833ef_D20220401-20220430", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.novocure.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001645113-22-000037-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001645113-22-000037-xbrl.zip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end